Gene-related cancer predisposition syndromes accounted for 16.7% (4/24) of ACMG SFs: MSH6 Lynch syndrome—1, BRCA1 hereditary breast and ovarian cancer (HBOC)—1, and PALB2 hereditary breast cancer (HBC)—2. Here, MSH6 is linked to Lynch syndrome.